IlluminOss provides a minimally invasive intramedullary fracture fixation system that delivers a light‑curable polymer via a percutaneous catheter, forming a patient‑specific implant that conforms to the medullary canal. The system includes fluoroscopic guidance, radiopaque markers, and a dedicated instrumentation kit to enable rapid fixation of fragility, periprosthetic, and oncologic long‑bone fractures and earlier patient mobilization.
Funding
$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conventional fracture fixation often requires extensive surgical exposure, prolonged operative time, and hardware that may not conform to complex bone geometries, leading to delayed mobilization, higher infection risk, and suboptimal outcomes for patients with fragility fractures or bone‑cancer‑related lesions.
Solution
IlluminOss delivers a minimally invasive intramedullary fracture repair system that combines percutaneous delivery of a light‑curable polymer with a customizable, patient‑specific implant. The polymer conforms to the internal canal of the bone, providing stable fixation while preserving surrounding soft tissue. Real‑time fluoroscopic guidance enables precise placement across multiple anatomical sites, including humerus, pelvis, femur, radius/ulna, fibula, and tibia. The system is designed for rapid postoperative recovery, allowing patients to resume daily activities sooner and reducing hospital length of stay. Comprehensive clinical resources, such as case illustrations and instruction‑for‑use documentation, support surgeon adoption and procedural consistency.
Target Audience
Primary customers are orthopedic and trauma surgeons, as well as hospital surgical departments that treat acute, fragility, and oncologic long‑bone fractures.
Features
- Percutaneous delivery catheter and light‑activation unit for in‑situ polymer curing
- Adjustable polymer volume that fills the medullary canal to match patient anatomy
- Radiopaque markers integrated into the polymer for fluoroscopic verification of implant position
- Compatibility with a broad range of long‑bone indications (humerus, pelvis, femur, radius/ulna, fibula, tibia)
- Dedicated instrumentation kit that streamlines preparation, insertion, and polymer curing steps
- FDA and CE cleared for use in fragility fractures, periprosthetic fractures, and bone‑cancer reconstruction
- Secure online portal providing IFU, surgical videos, and a library of peer‑reviewed case illustrations